Listed Funds Trust (MEDX)
Management Company · XNAS · Series S000078972 · View on SEC EDGAR ↗
Holdings data is not available for this fund yet.
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
MEDX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Performance as of March 10, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -0.57% | — |
| 3M | ▲ +3.00% | — |
| 6M | ▲ +16.35% | — |
| YTD | ▲ +2.61% | — |
| 1Y | ▲ +18.69% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since Feb. 27, 2024 | ▲ +11.93% | — |
- Volatility 1Y
- 21.21%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- —
- Sharpe 1Y*
- 0.93
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (Mar 2026)
- -$809K
- Quarter ending Mar 2026
- -$809K
- Trailing 12 months
- -$1.6M
Apr 2025 – Mar 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 33 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Eli Lilly & Co | 532457108 | $2.8M | 15.59 | 3,077 | EC | US |
| US BANK MMDA - USBGFS 7 | — | $1.8M | 10.03 | 1,820,804 | STIV | US |
| AbbVie Inc | 00287Y109 | $1.5M | 8.43 | 7,034 | EC | US |
| Novartis AG | 66987V109 | $1.3M | 7.40 | 8,791 | EC | CH |
| Johnson & Johnson | 478160104 | $1.1M | 5.93 | 4,401 | EC | US |
| AstraZeneca PLC | — | $1.0M | 5.71 | 5,256 | EC | GB |
| Bristol-Myers Squibb Co | 110122108 | $931K | 5.13 | 15,348 | EC | US |
| Ionis Pharmaceuticals Inc | 462222100 | $858K | 4.73 | 11,428 | EC | US |
| Amgen Inc | 031162100 | $760K | 4.19 | 2,161 | EC | US |
| Alnylam Pharmaceuticals Inc | 02043Q107 | $752K | 4.14 | 2,272 | EC | US |
| Alkermes PLC | — | $746K | 4.11 | 21,099 | EC | IE |
| Merck & Co Inc | 58933Y105 | $740K | 4.08 | 6,154 | EC | US |
| Pfizer Inc | 717081103 | $667K | 3.67 | 23,736 | EC | US |
| GSK PLC | 37733W204 | $570K | 3.14 | 10,319 | EC | GB |
| Biogen Inc | 09062X103 | $524K | 2.89 | 2,857 | EC | US |
| Regeneron Pharmaceuticals Inc | 75886F107 | $510K | 2.81 | 660 | EC | US |
| CRISPR Therapeutics AG | — | $460K | 2.53 | 9,671 | EC | CH |
| Beam Therapeutics Inc | 07373V105 | $209K | 1.15 | 8,791 | EC | US |
| Intellia Therapeutics Inc | 45826J105 | $169K | 0.93 | 13,188 | EC | US |
| Vanda Pharmaceuticals Inc | 921659108 | $164K | 0.90 | 23,736 | EC | US |
| Sandoz Group AG | 799926100 | $138K | 0.76 | 1,760 | EC | CH |
| Galectin Therapeutics Inc | 363225202 | $137K | 0.76 | 49,226 | EC | US |
| Haleon PLC | 405552100 | $129K | 0.71 | 12,900 | EC | GB |
| Replimune Group Inc | 76029N106 | $101K | 0.56 | 13,188 | EC | US |
| Editas Medicine Inc | 28106W103 | $72K | 0.39 | 29,010 | EC | US |
| GE HealthCare Technologies Inc | 36266G107 | $63K | 0.35 | 880 | EC | US |
| Bicycle Therapeutics PLC | 088786108 | $61K | 0.34 | 13,188 | EC | GB |
| Viatris Inc | 92556V106 | $44K | 0.24 | 3,272 | EC | US |
| Allogene Therapeutics Inc | 019770106 | $43K | 0.24 | 17,582 | EC | US |
| Lantern Pharma Inc | 51654W101 | $36K | 0.20 | 26,373 | EC | US |
| Pacific Biosciences of Califor | 69404D108 | $14K | 0.08 | 10,551 | EC | US |
| Decoy Therapeutics Inc | 79400X602 | $136 | 0.00 | 21 | EC | US |
| Pathos AI Inc | — | $0 | 0.00 | 23,992 | EC | US |
Institutional owners (13F) 8 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $422,209 | 58.87% | 11,500 | Shares | June 30, 2026 |
| HORIZON KINETICS ASSET MANAGEMENT LLC | $190,510 | 26.56% | 5,189 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $87,920 | 12.26% | 2,395 | Shares | June 30, 2026 |
| Global Retirement Partners, LLC | $9,803 | 1.37% | 267 | Shares | June 30, 2026 |
| HighMark Wealth Management LLC | $6,132 | 0.85% | 167 | Shares | June 30, 2026 |
| Virtu Financial LLC | $322 | 0.04% | 8,779 | Shares | June 30, 2026 |
| FMR LLC | $294 | 0.04% | 8 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $32 | 0.00% | 1 | Shares | June 30, 2026 |
Peer funds
Similar by size
| Fund | AUM |
|---|---|
| APXM First Trust Exchange-Traded Fun… | $18.2M |
| JMID Janus Detroit Street Trust | $18.2M |
| RSJN First Trust Exchange-Traded Fun… | $18.3M |
| NBCE Neuberger Berman ETF Trust | $18.3M |
| ABLG Abacus FCF ETF Trust | $18.3M |
| ZTWO RBB Fund, Inc. | $18.1M |
| PBMY PGIM Rock ETF Trust | $18.1M |
| TPOR Direxion Shares ETF Trust | $18.0M |
| QSIX Pacer Funds Trust | $18.0M |
| PSCU Invesco Exchange-Traded Fund Tr… | $17.9M |